Citation Impact
Citing Papers
Vaginal microbiome of reproductive-age women
2010 Standout
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
The Spring α-Helix Coordinates Multiple Modes of HCV (Hepatitis C Virus) NS3 Helicase Action
2016 StandoutNobel
Increased Thrombopoiesis and Platelet Activation in Hantavirus-Infected Patients
2015 StandoutNobel
Evidence for antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication.
1993
DETECTION OF HTV1 DNA IN INFANTS AND CHILDREN BY MEANS OF THE POLYMERASE CHAIN REACTION
1988 Standout
The Psychosocial Impact of Testing Individuals with No History of Genital Herpes for Herpes Simplex Virus Type 2
2004
Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision
2002
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Detection of human serum antibodies against type-specifically reactive peptides from the N-terminus of glycoprotein B of herpes simplex virus type 1 and type 2 by surface plasmon resonance
2000
Factors Predicting the Acceptance of Herpes Simplex Virus Type 2 Antibody Testing Among Adolescents and Young Adults
2004
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
A Controlled Trial Comparing Foscarnet with Vidarabine for Acyclovir-Resistant Mucocutaneous Herpes Simplex in the Acquired Immunodeficiency Syndrome
1991
Antiviral prodrugs – the development of successful prodrug strategies for antiviral chemotherapy
2005
Use of a Glycoprotein G-Based Type-Specific Assay to Detect Antibodies to Herpes Simplex Virus Type 2 Among Persons Attending Sexually Transmitted Disease Clinics
2001
National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications
2012 Standout
Valaciclovir Versus Acyclovir in the Treatment of First-Episode Genital Herpes Infection
1997
Hantavirus pulmonary syndrome
2011
Can available interventions end preventable deaths in mothers, newborn babies, and stillbirths, and at what cost?
2014 Standout
Therapeutic Approaches to Varicella-Zoster Virus Infections
1992
Neonatal Herpes Simplex Virus Infection in Relation to Asymptomatic Maternal Infection at the Time of Labor
1991
Limited Antibody‐Dependent Cellular Cytotoxicity Antibody Response Induced by a Herpes Simplex Virus Type 2 Subunit Vaccine
2000
Valacyclovir for the Suppression of Recurrent Genital Herpes in Human Immunodeficiency Virus–Infected Subjects
2003
Herpes simplex virus infections
2001
Congenital infections
2002
Antiherpes simplex virus type 2 activity of casuarinin from the bark of Terminalia arjuna Linn.
2002
Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial
2007 Standout
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
1997
Prevalence of HPV Infection Among Females in the United States
2007 Standout
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Hantavirus Pulmonary Syndrome: The New American Hemorrhagic Fever
2002
Aciclovir
1994
Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
Daily or Weekly Therapy with Resiquimod (R‐848) Reduces Genital Recurrences in Herpes Simplex Virus–Infected Guinea Pigs during and after Treatment
2001
Polymerase chain reaction for diagnosis of genital herpes in a genitourinary medicine clinic
2002
Transfusion Medicine — Blood Transfusion
1999 Standout
Once-daily valacyclovir hydrochloride for suppression of recurrent genital herpes
1999 StandoutNobel
Herpes simplex virus type 2 infection increases HIV incidence: a prospective study in rural Tanzania
2002
Transmission of Herpes Simplex Virus Type 2 among Factory Workers in Ethiopia
2004
Association between Acquisition of Herpes Simplex Virus Type 2 in Women and Bacterial Vaginosis
2003
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Comparative Efficacy of Famciclovir and Valacyclovir for Suppression of Recurrent Genital Herpes and Viral Shedding
2006
VIRAL HEMORRHAGIC FEVERS AND HANTAVIRUS INFECTIONS IN THE AMERICAS
1998
Sensorineural hearing loss in children
2005 Standout
Antibody to Herpes Simplex Virus Type 2 as a Marker of Sexual Risk Behavior in Rural Tanzania
1999
Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals
2000
Herpes simplex: Evolving concepts
1996
Changing AIDS-risk behavior.
1992 Standout
Malaria
2013 Standout
Genital Herpes and Public Health
2000
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster
2009
Serological Testing for Herpes Simplex Virus (HSV)–1 and HSV‐2 Infection
2002
Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: The RELIEF trial
2008
Graft-versus-host disease
2009 Standout
Herpes simplex virus type 2 serological testing and psychosocial harm: a systematic review
2011
Transfusion transmission of retroviruses: human T‐lymphotropic virus types I and II compared with human immunodeficiency virus type 1
1994
Potential Effect of HIV Type 1 Antiretroviral and Herpes Simplex Virus Type 2 Antiviral Therapy on Transmission and Acquisition of HIV Type 1 Infection
2005
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Effect of resveratrol on herpes simplex virus vaginal infection in the mouse
2005
Acyclovir-Resistant Varicella Zoster Virus Infection after Chronic Oral Acyclovir Therapy in Patients with the Acquired Immunodeficiency Syndrome (AIDS)
1990
Superspreading and the effect of individual variation on disease emergence
2005 StandoutNature
Progress and problems with the use of viral vectors for gene therapy
2003 Standout
Inactivation of HSV-1 and HSV-2 and prevention of cell-to-cell virus spread by Santolina insularis essential oil
2000
Genital herpes
2007
Rising incidence and prevalence of herpes simplex type 2 infection in a cohort of 26 year old New Zealanders
2001
Hemorrhagic fever virus-induced changes in hemostasis and vascular biology
2000
Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women
2001
The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection
2006
Hemophilia-associated AIDS in the United States, 1981 to September 1987.
1988
Three-Drug Synergistic Inhibition of HIV-l Replication In Vitro by Zidovudine, Recombinant Soluble CD4, and Recombinant Interferon-alpha A
1990
Recent Herpes Simplex Virus Type 2 Infection and the Risk of Human Immunodeficiency Virus Type 1 Acquisition in India
2003
Theories of reasoned action and planned behavior as models of condom use: A meta-analysis.
2001 Standout
Herpes simplex virus helicase-primase inhibitors are active in animal models of human disease
2002
Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies
2005 Standout
Trends in Herpes Simplex Virus Type 1 and Type 2 Seroprevalence in the United States
2006
Sexually transmitted diseases treatment guidelines
2003 Standout
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
2003 Standout
Acyclovir-Resistant Genital Herpes Among Persons Attending Sexually Transmitted Disease and Human Immunodeficiency Virus Clinics
2003
Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: A randomized double‐blind trial
1995
Performance of a novel test for IgM and IgG antibodies in subjects with culture-documented genital herpes simplex virus-1 or -2 -infection
2006
Resistance of Herpes Simplex Virus Infections to Nucleoside Analogues in HIV‐Infected Patients
2004
Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock*
2002
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway
2002 Standout
The Risk of Transfusion-Transmitted Viral Infections
1996 Standout
ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2
2010
The TNF and TNF Receptor Superfamilies
2001 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Reversal of virus-induced systemic shock and respiratory failure by blockade of the lymphotoxin pathway
1999
Herpes Zoster
2013 Standout
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Valaciclovir for the Suppression of Recurrent Genital Herpes Simplex Virus Infection: A Large‐Scale Dose Range‐Finding Study
1998
A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition
2009
Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial
2008
Herpes Zoster
2002 Standout
The Effects of Herpes Simplex Virus-2 on HIV-1 Acquisition and Transmission: A Review of Two Overlapping Epidemics
2004
The Acquisition of Herpes Simplex Virus during Pregnancy
1997
Biological effects of essential oils – A review
2007 Standout
Oral Famciclovir for the Suppression of Recurrent Genital Herpes<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
1998
Serum antibodies against the hepatitis C virus E2 protein mediate antibody-dependent cellular cytotoxicity (ADCC)
2005 StandoutNobel
Impacts of biodiversity on the emergence and transmission of infectious diseases
2010 StandoutNature
AIDS risk behavior patterns among gay men in small southern cities.
1990
Genital herpes and human immunodeficiency virus: double trouble.
2004
Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation—a randomized double-blind placebo-controlled study
2005
Adolescent Sexual Behavior, Drug Use, and Violence: Increased Reporting with Computer Survey Technology
1998 StandoutScience
Selective active site inhibitors of human lactate dehydrogenases A4, B4, and C411Abbreviations: LDH, lactate dehydrogenase; and LDH-A4, -B4, and -C4, human lactate dehydrogenases A4, B4, and C4.
2001
HUMAN-IMMUNODEFICIENCY-VIRUS INFECTIONS IN INFANTS NEGATIVE FOR ANTI-HIV BY ENZYME-LINKED IMMUNOASSAY
1987
Safety of famciclovir in patients with herpes zoster and genital herpes
1994
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
A gradient of childhood self-control predicts health, wealth, and public safety
2011 Standout
Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques
1997
Varicella-zoster virus
1996 Standout
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase.
1994 Standout
Experimental Therapy of Human Glioma by Means of a Genetically Engineered Virus Mutant
1991 Science
Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection
2008
Emerging Infectious Diseases of Wildlife-- Threats to Biodiversity and Human Health
2000 StandoutScience
Electrochemiluminescence (ECL)
2004 Standout
Progressive engineering of a homing endonuclease genome editing reagent for the murine X-linked immunodeficiency locus
2014 StandoutNobel
Education, HIV, and Early Fertility: Experimental Evidence from Kenya
2015 StandoutNobel
NITRIC OXIDE AND MACROPHAGE FUNCTION
1997 Standout
Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs
1994
Male‐male sexual contact in the U.S.A.: Findings from five sample surveys, 1970–1990
1991
Human T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors
1993
Puumala Hantavirus Viremia Diagnosed by Real-Time Reverse Transcriptase PCR Using Samples from Patients with Hemorrhagic Fever and Renal Syndrome
2007
Sexual behaviour in aids‐related research: Reliability and validity of recall and diary measures
1990
Antiviral Efficacy of Favipiravir against Two Prominent Etiological Agents of Hantavirus Pulmonary Syndrome
2013
Frequency–dependent incidence in models of sexually transmitted diseases: portrayal of pair–based transmission and effects of illness on contact behaviour
2004
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Incidence Trends for Human Papillomavirus–Related and –Unrelated Oral Squamous Cell Carcinomas in the United States
2008 Standout
Epidemiology and burden of malaria in pregnancy
2007
Targeted DNA Mutagenesis for the Cure of Chronic Viral Infections
2012
Valaciclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once daily therapy. International Valaciclovir HSV Study Group.
1997
Evaluation of Confirmatory Strategies for Detection of Type-Specific Antibodies against Herpes Simplex Virus Type 2
2002
Parâmetros de prática clínica para suporte hemodinâmico a pacientes pediátricos e neonatais em choque séptico
2002
Behavioral risk reduction for HIV infection among gay and bisexual men: A review of results from the United States.
1988
The Relationship between Condom Use and Herpes Simplex Virus Acquisition
2005
Update of Practice Guidelines for the Management of Community-Acquired Pneumonia in Immunocompetent Adults
2003
Clinical Reactivation of Genital Herpes Simplex Virus Infection Decreases in Frequency over Time
1999
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
1994
Works of Grégory Mertz being referenced
Double-Blind, Placebo-Controlled Trial of a Herpes Simplex Virus Type 2 Glycoprotein Vaccine in Persons at High Risk for Genital Herpes Infection
1990
Cardiopulmonary manifestations of hantavirus pulmonary syndrome
1996
Treatment of hantavirus pulmonary syndrome
2007
Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol
1991
Sorivudine versus Acyclovir for Treatment of Dermatomal Herpes Zoster in Human Immunodeficiency Virus-Infected Patients: Results from a Randomized, Controlled Clinical Trial
1998
Discriminators between Hantavirus-Infected and -Uninfected Persons Enrolled in a Trial of Intravenous Ribavirin for Presumptive Hantavirus Pulmonary Syndrome
2002
Incidence of Hairy Cell Leukemia, Mycosis Fungoides, and Chronic Lymphocytic Leukemia in First Known HTLV-II-Endemic Population
1991
Disseminated Herpes Zoster in the Immunocompromised Host: A Comparative Trial of Acyclovir and Vidarabine
1992
Acyclovir-Resistant Herpes Simplex Virus Infections in Patients with the Acquired Immunodeficiency Syndrome
1989
Transmission of Genital Herpes in Couples with One Symptomatic and One Asymptomatic Partner: A Prospective Study
1988
Management of Genital Herpes
1996
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
2003
Prospective Evaluation of Household Contacts of Persons with Hantavirus Cardiopulmonary Syndrome in Chile
2007
Transmission of HTLV‐II via Blood Transfusion
1990
Recurrence and Resistance Patterns of Herpes Simplex Virus following Cessation of >=6 Years of Chronic Suppression with Acyclovir
1994
Placebo-Controlled, Double-Blind Trial of Intravenous Ribavirin for the Treatment of Hantavirus Cardiopulmonary Syndrome in North America
2004
Risk Factors for the Sexual Transmission of Genital Herpes
1992
Oral Famciclovir for Suppression of Recurrent Genital Herpes Simplex Virus Infection in Women
1997
Persistence of High-Risk Sexual Activity among Homosexual Men in an Area of Low Incidence of the Acquired lmmunodeficiency Syndrome
1987
New developments in the epidemiology, natural history and management of genital herpes
1999
EPIDEMIOLOGY OF GENITAL HERPES INFECTIONS
1993
Double-blind Placebo-Controlled Trial of Oral Acyclovir in First-Episode Genital Herpes Simplex Virus Infection
1984
Long-term Acyclovir Suppression of Frequently Recurring Genital Herpes Simplex Virus Infection
1988
Locations of herpes simplex virus type 2 glycoprotein B epitopes recognized by human serum immunoglobulin G antibodies
1996
Transmission of Genital Herpes in Couples With One Symptomatic and One Asymptomatic Partner: A Prospective Study
1989
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection.
1988
Incubation Period of Hantavirus Cardiopulmonary Syndrome
2006
A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection
1984
Treatment of primary first-episode genital herpes simplex virus infections with acyclovir: results of topical, intravenous and oral therapy
1983
Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group
1997
Prevalence of HTLV-III antibody among New Mexico residents with hemophilia.
1986
Congenital malaria: A report of four cases and a review
1982
Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
2004
First Human Isolate of Hantavirus (Andes virus) in the Americas
2002
A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection
1984